Terms of Use


PLEASE READ AND REVIEW THE FOLLOWING TERMS OF USE AGREEMENT CAREFULLY BEFORE USING THIS WEB SITE OPERATED BY PRESTIUM PHARMA, INC.


By using this Internet website (the "Site"), you agree to this Terms of Use Agreement (these "Terms of Use").  If you do not agree and do not wish to be bound by these Terms of Use, please exit the Site and do not use the Site in the future.


This Site is owned and operated by Prestium Pharma, Inc. ("Prestium Pharma").


This Site and its contents are designed to comply with U.S. laws and regulations.  Although accessible to others outside the U.S. through the Internet, product information provided herein is intended for U.S. residents only.


1. Acceptance. By using this Site, you agree to be bound by and to comply with these Terms of Use.  Prestium Pharma reserves the right to change these terms from time to time, as it deems to be necessary.  You may view the current applicable version of these Terms of Use at any time through a link at the bottom of each page within this Site.


2. Scope. The terms of use set forth in this agreement apply only to your use of this Site.  Prestium Pharma may operate other sites and those sites are covered by their own conditions as specified within those web sites.


3. Medical Information/Conditions. While there may be information on this Site related to certain medical conditions and their treatment, should a medical condition exist, promptly see your own physician or health care provider.  We do not offer personalized medical diagnosis or patient-specific treatment advice. Indeed, only your doctor or other health care professional, can determine if a product described in this, or any, web site is appropriate for you.


PLEASE CONSULT WITH YOUR DOCTOR, OR OTHER QUALIFIED HEALTH CARE PROFESSIONAL BEFORE USING ANY PRODUCT DISCUSSED WITHIN THIS, OR ANY OTHER, WEB SITE.


4. Description of Services. This Site contains material about Prestium Pharma and its various products. Please feel free to browse this Site, as appropriate. Your access to and use of the information contained herein is subject to these Terms of Use and all applicable laws.  By accessing and browsing this Site, you accept, without limitation or qualification, these Terms of Use.


5.  Use of Site. Prestium Pharma grants you permission to display, copy, and download the materials on this Site for personal, noncommercial use only, provided you do not modify the materials and that you retain all copyright and other proprietary notices contained in the materials.  Except as expressly provided herein, you may not otherwise copy, display, download, distribute, modify, reproduce, republish or retransmit any information, text, documents, or images contained in this Site or any portion thereof in any electronic medium or in hard copy, or create any derivative work based on such text, documents, or images without the express written consent of Prestium Pharma. You may not "mirror" any material contained on this Site on any other server without prior the written permission of Prestium Pharma.  You agree that you will not use any software, device, or any other means to interfere with the proper working of this Site.


6.  Trademarks/Proprietary Rights. You should assume that all product names appearing on this website, whether or not appearing in large print or with the trademark symbol are trademarks of Prestium Pharma, or its affiliates, licensors, or joint venture partners.  This website may also contain or reference patents, proprietary information, technologies, products, processes or other proprietary rights of Prestium Pharma and/or other parties.  No license to rights in any such trademarks, patents, trade secrets, technologies, products, processes and proprietary rights of Prestium Pharma and/or other parties is granted to or conferred upon you.


7. Privacy Notice and Submissions. Please refer to Prestium Pharma’s Internet Privacy Policy for information on how we protect your Personal Information. Any communications regarding non-personal information including questions, comments, data, or know-how, shall be considered to be non-confidential and shall become the property of Prestium Pharma, without compensation to the provider of such submissions. Prestium Pharma shall have no obligation of any kind with respect to such information and shall be free to use any ideas, concepts, know-how, techniques or inventions contained therein for any purpose, including but not limited to developing, manufacturing and marketing products and services.


8. Links to Other Web Sites. This Site may contains links to other Prestium Pharma and non-Prestium Pharma Internet web sites. Prestium Pharma assumes no responsibility for the content of non-Prestium Pharma Internet web sites to which we provide links.


9. Disclaimer of Warranties. Prestium Pharma has taken reasonable measures to ensure that the information contained within this Site is reliable, however, by using this Site, you accept the information, products and services provided herein "AS IS." Prestium Pharma makes no express or implied warranty regarding the accuracy, content, completeness, reliability, operability, or legality of information contained within this Site, including, without limitation, the warranties of merchantability, fitness for a particular purpose, and non-infringement of proprietary rights.


10. Consequences. Prestium Pharma reserves the right to suspend or terminate your usage of this Site if you violate these Terms of Use.  If your violation causes harm to others, you agree to indemnify and hold Prestium Pharma harmless from and against any and all loss, damage, or expense.  If any dispute arises between us regarding this Agreement or your use of this Site, it shall be resolved through good faith negotiations between the parties.  If such efforts prove unsuccessful, all such controversies, claims, or disputes shall be submitted to binding arbitration pursuant to the Federal Arbitration Act, 9 U.S.C., §1 et seq. Arbitration shall be conducted in accordance with the rules of the American Arbitration Association.  The arbitration award shall be final and binding, and it may be confirmed and enforced in any court of competent jurisdiction.  Each party shall pay for all attorney fees it incurred in connection with the arbitration and shall share equally in the costs of the arbitration. The venue for any arbitration shall be New Jersey.


Copyright and Trademark Notices


All contents of the Prestium Pharma Web Site are: Copyright 2013 Prestium Pharma, Inc.


All rights reserved.




Important Safety Information


Denavir should only be used on herpes labialis on the lips or face. Application to mucous membranes is not recommended. Denavir should not be used in patients with known hypersensitivity to the product or any of its ingredients.


There are no adequate and well-controlled Denavir studies in pregnant women; therefore, Denavir should be used during pregnancy only if clearly needed. There is no information on whether Denavir is excreted in human milk after topical administration; a decision whether to discontinue Denavir should take into account the importance of the drug to the mother. The effect of Denavir has not been established in immunocompromised patients. Denavir does not cure cold sores.


In clinical studies, the most common adverse reaction with Denavir was headache, which occurred in 5.3% of patients who received Denavir and 5.8% of patients who received placebo. Other adverse reactions with Denavir occurred in less than 2% of patients and included application site reaction, decreased sensitivity to touch/local anesthesia, taste perversion, and rash.


Other reported adverse reactions have included swelling of the mouth or throat, pain, alterations in sense of smell, abnormal touch sensation, itching, skin discoloration, and hives.


Denavir is available by prescription only. Please see the Full Prescribing Information.


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

 












DENAVIR is a nucleoside analog HSV DNA polymerase inhibitor indicated for the treatment of recurrent herpes labialis (cold sores) in adults and children 12 years of age and older.